|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: RETRACTABLE TECHNOLOGIES INC, 10SB12G/A, EX-12.2, 2000-10-25 |
Next: VIROPHARMA INC, 8-K, 2000-10-25 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<RESTATED>
<S> <C> <C>
<PERIOD-TYPE> YEAR 3-MOS
<FISCAL-YEAR-END> DEC-31-1999 DEC-31-2000
<PERIOD-START> JAN-01-1999 APR-01-2000
<PERIOD-END> DEC-31-1999 JUN-30-2000
<CASH> 646,005 6,812,253
<SECURITIES> 0 966,897
<RECEIVABLES> 610,396 (10,351)
<ALLOWANCES> (10,972) 1,496,993
<INVENTORY> 677,962 9,451,062
<CURRENT-ASSETS> 1,971,191 13,803,359
<PP&E> 12,673,889 (3,045,981)
<DEPRECIATION> (2,572,365) (3,045,981)
<TOTAL-ASSETS> 13,208,729 20,761,724
<CURRENT-LIABILITIES> (2,014,841) (2,299,542)
<BONDS> 0 0
0 0
(8,160,200) (9,294,245)
<COMMON> (1,000) (1,000)
<OTHER-SE> (526,353) (6,741,584)
<TOTAL-LIABILITY-AND-EQUITY> (13,208,729) (20,761,724)
<SALES> (3,375,158) (1,528,488)
<TOTAL-REVENUES> (3,375,158) (1,528,488)
<CGS> 2,331,070 1,691,891
<TOTAL-COSTS> 9,286,660 2,168,748
<OTHER-EXPENSES> 0 0
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> (9,064) 37,637
<INCOME-PRETAX> 8,223,508 2,294,514
<INCOME-TAX> 0 0
<INCOME-CONTINUING> 8,223,508 2,294,514
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> 8,223,508 2,294,514
<EPS-BASIC> 0 0
<EPS-DILUTED> 0 0
</TABLE>
|
|